RESUMO
Despite the extensive efforts that have been made to combat AIDS, the global number of HIV-1 infections is still increasing. There is major consent among scientists worldwide, that the development of successful HIV vaccine strategies requires a profound understanding of the epidemiological principles of a viral pandemic, as well as deep insights into the molecular and immunological mechanisms of HIV pathogenesis. This review provides an overview of past and present developments, as well as future aspects of HIV vaccines, and also provides a summary of current clinical trials in man.
Assuntos
Vacinas contra a AIDS , Infecções por HIV/prevenção & controle , Vacinas contra a AIDS/química , Vacinas contra a AIDS/história , Vacinas contra a AIDS/imunologia , Ensaios Clínicos como Assunto , Europa (Continente) , Infecções por HIV/imunologia , História do Século XX , História do Século XXI , HumanosRESUMO
There is a significant variation of codon usage bias among different species and even among genes within the same organisms. Codon optimization, this is, gene redesigning with the use of codons preferred for the specific expression system, results in improved expression of heterologous genes in bacteria, plants, yeast, mammalian cells, and transgenic animals. The mechanisms preventing expression of genes with rare or low-usage codons at adequate levels are not completely elucidated. Human immunodeficiency virus (HIV) represents an interesting model for studying how differences in codon usage affect gene expression in heterologous systems. Construction of synthetic genes with optimized codons demonstrated that the codon-usage effects might be a major impediment to the efficient expression of HIV gag/pol and env gene products in mammalian cells. According to another hypothesis, the poor expression of HIV structural proteins even without HIV context is attributed to the so-called cis-acting inhibitory elements (INS), which are located within the protein-coding region. They consist of AU-rich sequences and may be inactivated through the introduction of multiple mutations over the large regions of gag gene. In our work, we evaluated expression of hybrid HIV-1 gag mRNAs where wild-type (A-rich) gag sequences were combined with artificial sequences. In such "humanized" gag fragments with adapted codon usage, AT-content was significantly reduced in favor of G and C nucleotides without any changes in protein sequence. We show that wild-type gag sequences negatively influence expression of gag-reporter, and the addition of fragments with optimized codons to gag mRNA partially rescues its expression. The results demonstrate that the expression of HIV-1 gag is determined by the ratio of optimized and rare codons within mRNA. Our data also indicates that some wtgag fragments counteract the influence of the other wtgag sequences, which cause the inhibition of gag expression. The presented data do not contradict the concept of INS; yet, it makes the definition of INS more complex. This supports the idea of a broader role of the selected codon usage in influencing the expression of HIV proteins in mammalian cells.
Assuntos
Códon/genética , Regulação Viral da Expressão Gênica , Genes gag/genética , HIV-1/genética , Proteínas Recombinantes de Fusão/genética , Produtos do Gene gag/genética , Vetores Genéticos , Humanos , Plasmídeos , Precursores de Proteínas/genética , RNA Mensageiro/genética , Transfecção , Células Tumorais CultivadasRESUMO
We have analysed the influence of size, intracellular localisation, and sorting of various human immunodeficiency virus type 1 (HIV-1)-derived Gag and Env polypeptides containing well defined H2(d)-restricted cytotoxic T lymphocyte (CTL) epitopes on the induction of a humoral and cellular immune response after DNA vaccination. Thus, expression vectors were generated based on RNA- and codon-optimised genes encoding (i). budding competent full-length Gag, (ii). a myristylation defect mutant GagMyr(-), (iii). the isolated p24 capsid moiety of Gag as well as variants of these proteins, which were C-terminally fused HIV gp120-derived V3 epitope (R10I), respectively. These constructs were compared to different minitopes each encoding one of the H2(d)-restricted Gag epitopes A9I and E10F or the V3 epitope R10I that were directly linked to the C-terminus of an Ad2-E3 protein-derived ER signal peptide. Immunological evaluation of these constructs in BALB/c mice revealed that both, the budding competent as well as the intracellular Gag proteins were-irrespective of their molecular weights-equally efficient in the priming of Gag-specific humoral and cellular immune responses. In addition, the capacity of these constructs to stimulate Gag-specific humoral as well as H2-K(d) and H2-L(d) restricted cellular immune responses was not influenced by C-terminal fusion of the immunodominant H2-D(d) restricted V3 epitope. Chimeric GagV3 polyproteins encoding all three major CTL epitopes within a continuous polyprotein were more efficient to stimulate epitope-specific cellular immune responses than the selected minitopes. In addition, the minitopes failed to induce epitope-specific antibody responses. These results clearly show the advantages of complex polypeptides over minitopes regarding the induction of strong humoral and cellular immune responses.
Assuntos
Vacinas contra a AIDS/imunologia , Epitopos/imunologia , HIV-1/imunologia , Imunidade Celular/imunologia , Peptídeos/imunologia , Linfócitos T Citotóxicos/imunologia , Vacinas contra a AIDS/genética , Animais , Formação de Anticorpos , Códon/genética , Citocinas/análise , Citocinas/biossíntese , Primers do DNA , Epitopos/genética , Feminino , Produtos do Gene env/imunologia , Produtos do Gene gag/imunologia , Genes MHC Classe I/imunologia , HIV-1/genética , Imunidade Celular/genética , Camundongos , Camundongos Endogâmicos BALB C , Peptídeos/genética , Plasmídeos/genética , Plasmídeos/imunologia , RNA/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Vacinas de DNA/genética , Vacinas de DNA/imunologiaRESUMO
Most studies on DNA-based immunization have used viral promoters to drive antigen expression. In this study, we analyzed the properties of the commonly used CMV promoter, the tissue specific murine muscle creatine kinase (MCK) promoter as well as a hybrid MCK/CMV promoter regarding promoter activity and tissue specificity in vitro. Furthermore, the efficiency of inducing HIV-1 Gag specific immune responses in vivo following intramuscular immunization of naked DNA containing a codon optimized synthetic gene was compared. Although antibody titers and cellular immune responses using the MCK construct were slightly reduced as compared to conventional CMV based vector modules, the utilization of nonviral promoters may add significantly to the safety of future DNA vaccines.
Assuntos
Vacinas contra a AIDS/imunologia , Creatina Quinase/genética , Citomegalovirus/genética , Elementos Facilitadores Genéticos , Produtos do Gene gag/imunologia , Genes gag , Proteína do Núcleo p24 do HIV/imunologia , HIV-1/imunologia , Isoenzimas/genética , Músculo Esquelético/metabolismo , Regiões Promotoras Genéticas , Precursores de Proteínas/imunologia , Vacinas de DNA/imunologia , Vacinas contra a AIDS/genética , Animais , Especificidade de Anticorpos , Creatina Quinase Forma MM , Feminino , Produtos do Gene gag/genética , Genes Reporter , Genes Sintéticos , Anticorpos Anti-HIV/biossíntese , Anticorpos Anti-HIV/imunologia , Proteína do Núcleo p24 do HIV/genética , HIV-1/genética , Humanos , Luciferases/biossíntese , Luciferases/genética , Neoplasias Pulmonares/patologia , Camundongos , Camundongos Endogâmicos BALB C , Especificidade de Órgãos , Precursores de Proteínas/genética , Transcrição Gênica , Células Tumorais Cultivadas , Vacinas de DNA/genética , Vacinas Sintéticas/genética , Vacinas Sintéticas/imunologiaRESUMO
Most studies on DNA-based immunization have used viral promoters to drive antigen expression. Recently, the use of tissue-specific DNA vaccines has been favored regarding safety issues. In this study, we determined the impact of antigen localization and tissue-specific expression on the induction of humoral as well as cellular immune responses in a BALB/c mouse model. Thereby, we show that using the muscle-specific muscle creatine kinase (MCK) promoter/enhancer the efficiency of immune stimulation is strictly dependent on the ability of HIV-1 Pr55(gag) to be released from cells. By contrast, localization of Pr55(gag) and derivatives thereof plays only a minor role when antigen is constitutively expressed using the ubiquitous viral CMV promoter.
Assuntos
Vacinas contra a AIDS/imunologia , Creatina Quinase/genética , Elementos Facilitadores Genéticos , Produtos do Gene gag/imunologia , Proteína do Núcleo p24 do HIV/imunologia , HIV-1/imunologia , Isoenzimas/genética , Músculo Esquelético/metabolismo , Regiões Promotoras Genéticas , Precursores de Proteínas/imunologia , Vacinas de DNA/imunologia , Animais , Especificidade de Anticorpos , Creatina Quinase Forma MM , Produtos do Gene gag/análise , Produtos do Gene gag/genética , Genes Sintéticos , Genes gag , Anticorpos Anti-HIV/biossíntese , Proteína do Núcleo p24 do HIV/análise , Proteína do Núcleo p24 do HIV/genética , HIV-1/genética , Humanos , Imunidade Celular , Camundongos , Camundongos Endogâmicos BALB C , Especificidade de Órgãos , Precursores de Proteínas/análise , Precursores de Proteínas/genética , Linfócitos T Citotóxicos/imunologia , Células Th1/imunologia , Células Th2/imunologia , Vacinas Sintéticas/genética , Vacinas Sintéticas/imunologiaRESUMO
In this study, we analyzed the in vitro expression, potency and longevity of immune responses induced in a Balb/c mouse model by a synthetic HIV-1 GAG gene exhibiting a codon usage that was adapted to that of highly expressed mammalian genes (syngag). In contrast to a vector containing the wild-type (wt) GAG gene, the syngag construct enabled highly efficient Gag expression in both human and rodent cell lines in complete absence of Rev and Rev-responsive element. Immunization of Balb/c mice with the wt gag plasmid DNA induced only weak and inconsistent humoral immune responses. Mice vaccinated by syngag but not wt gag developed substantial and highly consistent Gag-specific antibody titers showing a clear T helper 1 polarization even with low doses of DNA. Moreover, vaccinated mice developed a strong Gag-specific cellular immune response, including cytotoxic T cells, which was not observed in wt gag-immunized animals. Both humoral and cellular immunity were efficient and lasted for more than 20 weeks. Furthermore, the induction of the humoral as well as the cellular immune response was independent of the immunization route (intramuscular or subcutaneous). These results clearly show the advantages of codon-optimized genes with respect to the expression and immunogenicity of plasmid DNA constructs, making them promising vaccine candidates for further studies.